Kruse: DSA: Drugs for movement disorders Flashcards

(48 cards)

1
Q

MAO-A preferentially metabolizes

A

norepinephrine and serotonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MAO-B preferentially metabolizes

A

phenylethylamine and benzylamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

drugs equally metabolized by MAO-A and B

A

dopamine and tryptamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

selegiline

A

irreversible MAO-B inhibtior (inhibtis MAO-A at high doses)

-slows breakdown of dopamine to prolong effects of levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

selegiline is contraindicated in pts taking

A

TCAs, SSRIs, or meperidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

rsaagiline

A

irreversible inhibitor of MAO-B, more potent than selegiline

-treatment for early symptomatic PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what most not be given with levodopa

A

nonselective MAO inhibtor bc of hypertensive crisis with accumulation of norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COMT and levodopa

A

metaboloizes it to 3-O-methyldopa, which competes with levodopa for transport across the intestinal mucosa and BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COMT inhibitors _____ and _____ prolon activity of levodopa by inhibting peripheral metabolism

A

tolcapone (central and peripheral effects) and entacapone (peripheral effects only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

side effefcts of tolcapone

A

may cause increase in liver enzyme levels

  • rarely associated death from acute hepatic failure
  • side effects usually due to levodopa but include orange urine, diarrhea, ab pain, sleep disturbance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

apomorphine use

A

dopamine agonist that acts at D2 receptors in caudate-putamen

-temporary relief of off-periods of akinesia in pts on dopaminergic therapy (benefit is 10 mintues)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

apomorphine side effes

A

nausea (pretreat with antiemetic trimethobenzamide)

dyskinesias, drowsiness, sweating, hypotension, and injection site bruising

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

amantadine

A

antivairal agent whose MOA in parkinsomism is unknown

  • half-life 2-4 hours, peak at 1-4 hrs
  • may potentiate dopaminergic fnct by infulencing syn, release or reuptake of dopamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

amantadine adverse effects

A

restlessness, depression, irritability, insomnia, agitation, excitement, hallucinations, confusion

may cause livedo reticularis (purple discolor of skin on legs)

-use with caution in pts with history of seizures or heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mAChR antagonist may improve what but not what

A

tremor and rigidity but little effect on bradykinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

anticholinergic agents used in PD

A

benztropine, biperiden, orphenadrine, procyclindine, trihexyphenidyl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

AE of anticholinergic agents for PD

A

peripheral anticholinergic effects

sedation, mental confusion, constipation, urinaryu retention, blurred vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

B1 receptors have been impicated in some tremors and these respond well to

A

metoprolol and propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

symptomatic tremor can be controlled by antiepileptic drug ___ in smaler doses than those used to treat seizurews

A

primidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

topirimate

A

serotonin receptor agonist, effective in treatment of temor

21
Q

alprazolam

A

(benzo) along with IM injections of botulinum toxin A have been effective in some pts with tremor

22
Q

what drugs often alleviate chorea

A

drugs that impair dopaminergic NT like reserpine and tetrabenzine

-block vesicular monoamine transporter and deplete cerebral dopamine stores

23
Q

what enzymes are decreased in huntingtons

A

GABA glutamic acid decarboxylase (syn GABA) and choline acetyltransferase reduced in basal ganglia

-

24
Q

treatment for tics (most predictive and effective)

A

neuroleptic antipsychotics like pimozide

-bad side effects so not always first choice

25
better choice for treatment of tics with less side effects
clonidine and guanfacine
26
restless leg syndrome
respond to dopmaine agonist: levodopa, diazepam, conazepam, or opiates -first line treatment is dopamine agonist PRAMIPEXOLE and ROPINIROLE
27
ALS treament
riluzole only drug to have impact on survival in ALS (few months) - MOA: inhibtis glutamate release and blocks postsynaptic NMDA and kainite type glutamate receptors - inhibtis voltage dep sodium channels, - major AE are nausea and weakness
28
Wilson disease
recessively inherited disorder of copper metabolism characteriszed by - biochem reduction in ceruloplasmin - increased copper in brain and viscera - signs of hepatic and neuro dysfunction
29
treatment of wilson diseae
agents that reduce serum copper levels and low copper diet - penicillamine: chelating agent that forms stable complex with copper and readily excreted by kidney - potassium disulfide: reduces intestinal absorption of copper - trientine, zinc acetate, and zinc sulfate
30
tremor
involuntary trembling or quivering
31
postural tremor
tremor of a part during movement (outstretched upper limb when lifting a cup)
32
essential tremor
termor of a part during movement
33
levodopa MOA
agonist at dopamine receptor mainly D2 - rapid absorbtion from SI, peak concentration at 1-2 hours - halflife is 1-3 hrs - 1-3% of levodopa actually enters brain unaltered bc rest is metabolzied by decarboxylation to dopamine - administer with DOPA decarboxylase inhibtor that does not corss BBB (carbidopa)
34
best clinical result of levodopa
during first few years of treament | -wearing off phenomenon can occur during long term treatment
35
AE levodopa: GI
in absence peripheral decarboxylase inhibitor causes anorexia, nausea and vomiting in 80% of pts, only 20% if given with carbidopa
36
AE levodopa: cardiovascular
postural hypotension hypertension with large doses or levodopa in combo with nonselective MAO inhibtior
37
AE levodopa dyskinesias
occur in 80% of pts | choreoathetosis
38
AE levodopa: behavior effectws
depression, anxiety, agitiation, insomnia -atypical antipsychotic agents help counteract
39
AE levodopa fluctuations in response on off pehnomenon
off periods: marked akinesia alternate over course of few hours with on periods of improved mobility -subcut injection of apomorphine may provide temp benefit to those pts with severe off-periods
40
contraindications of levodopa
pscyhotic pts, pts with angle closure glaucoma, pts with history of melanoma, caution with pts with active peptic ulcer
41
bromocriptine
D2 agonist 28% bioavail, peak 1-3 hrs, 1/2 life = 15 hours -extensive first pass metabolism
42
dopamine receptor agonist
bromocriptine pramipexole ropinirole
43
pramipexole
affinty for D3 receptors -treat RLS peak 2 hours, half life 8 hours -90% excreted unchanged in urine
44
ropiniirole
D2 recetpors agonist preference approved for RLS -metabolized by CYP1A2, if given with other agents metabolized by this enzyme, may reduce clearnce -peak 1-2 hours, half life 6 hours
45
AE dopamine agonist: GI
anorexia, nausea, vomitin | constipation, dyspepsia, refulx esophagitis
46
AE dopamine agonist: cardriovascular
postural hypotension bromocriptine may cause digital vasospasm -if have peripheral edema and cardiac arrhythmias then discontinue therapy
47
AE dopamine agonist: mental distubrnaces
confusion, hallucinations, delusions,
48
contraindications to using dopamine receptor agonist
pts with history of psychotic illness, recent myocardial infarction, or with active peptic ulceration